Cargando…
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cl...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082556/ https://www.ncbi.nlm.nih.gov/pubmed/30089139 http://dx.doi.org/10.1371/journal.pone.0201335 |
_version_ | 1783345822288576512 |
---|---|
author | Vasseur, Michèle Simon, Nicolas Picher, Chloé Richeval, Camille Soichot, Marion Humbert, Luc Barthélémy, Christine Fleury-Souverain, Sandrine Bonnabry, Pascal Décaudin, Bertrand Allorge, Delphine Odou, Pascal |
author_facet | Vasseur, Michèle Simon, Nicolas Picher, Chloé Richeval, Camille Soichot, Marion Humbert, Luc Barthélémy, Christine Fleury-Souverain, Sandrine Bonnabry, Pascal Décaudin, Bertrand Allorge, Delphine Odou, Pascal |
author_sort | Vasseur, Michèle |
collection | PubMed |
description | BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS: A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (Anioxyspray(TM), Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(−2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (Eff(Q), %). The proportion of Eff(Q) ≥ 90% was assessed by a Fisher’s exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CR(C) = 25.3% vs. CR(I) = 10.4%; OR = 0.341; p<0.0001). Overall Eff(Q) values (median; 1(st) and 3(rd) quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an Eff(Q) ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION: Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied. |
format | Online Article Text |
id | pubmed-6082556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-60825562018-08-28 A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study Vasseur, Michèle Simon, Nicolas Picher, Chloé Richeval, Camille Soichot, Marion Humbert, Luc Barthélémy, Christine Fleury-Souverain, Sandrine Bonnabry, Pascal Décaudin, Bertrand Allorge, Delphine Odou, Pascal PLoS One Research Article BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS: A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (Anioxyspray(TM), Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(−2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (Eff(Q), %). The proportion of Eff(Q) ≥ 90% was assessed by a Fisher’s exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CR(C) = 25.3% vs. CR(I) = 10.4%; OR = 0.341; p<0.0001). Overall Eff(Q) values (median; 1(st) and 3(rd) quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an Eff(Q) ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION: Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied. Public Library of Science 2018-08-08 /pmc/articles/PMC6082556/ /pubmed/30089139 http://dx.doi.org/10.1371/journal.pone.0201335 Text en © 2018 Vasseur et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vasseur, Michèle Simon, Nicolas Picher, Chloé Richeval, Camille Soichot, Marion Humbert, Luc Barthélémy, Christine Fleury-Souverain, Sandrine Bonnabry, Pascal Décaudin, Bertrand Allorge, Delphine Odou, Pascal A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title | A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title_full | A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title_fullStr | A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title_full_unstemmed | A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title_short | A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study |
title_sort | decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. a prospective, parallel study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082556/ https://www.ncbi.nlm.nih.gov/pubmed/30089139 http://dx.doi.org/10.1371/journal.pone.0201335 |
work_keys_str_mv | AT vasseurmichele adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT simonnicolas adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT picherchloe adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT richevalcamille adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT soichotmarion adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT humbertluc adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT barthelemychristine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT fleurysouverainsandrine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT bonnabrypascal adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT decaudinbertrand adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT allorgedelphine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT odoupascal adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT vasseurmichele decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT simonnicolas decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT picherchloe decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT richevalcamille decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT soichotmarion decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT humbertluc decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT barthelemychristine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT fleurysouverainsandrine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT bonnabrypascal decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT decaudinbertrand decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT allorgedelphine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT odoupascal decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy |